Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Equity

v3.23.1
Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   41,736,950    
Beginning balance at Dec. 31, 2021 $ 112,550 $ 417 $ 342,765 $ (230,632)
Increase (Decrease) in Stockholders' Equity        
Net loss (11,475)     (11,475)
Stock-based compensation 2,678   2,678  
Issuance of restricted and performance stock units (in shares)   215,287    
Issuance of restricted and performance stock units 0 $ 2 (2)  
Exercise of stock options and employee stock purchase plan (in shares)   20,750    
Exercise of stock options and employee stock purchase plan 98 $ 1 97  
Ending balance (in shares) at Mar. 31, 2022   41,972,987    
Ending balance at Mar. 31, 2022 $ 103,851 $ 420 345,538 (242,107)
Beginning balance (in shares) at Dec. 31, 2022 42,445,517 42,445,517    
Beginning balance at Dec. 31, 2022 $ 100,999 $ 424 360,155 (259,580)
Increase (Decrease) in Stockholders' Equity        
Net loss (7,074)      
Stock-based compensation 2,954   2,954  
Issuance of restricted and performance stock units (in shares)   238,719    
Issuance of restricted and performance stock units 0 $ 3 (3)  
Exercise of stock options and employee stock purchase plan (in shares)   125,758    
Exercise of stock options and employee stock purchase plan $ 634 $ 1 633  
Ending balance (in shares) at Mar. 31, 2023 42,809,994 42,809,994    
Ending balance at Mar. 31, 2023 $ 97,513 $ 428 $ 363,739 $ (266,654)